Regulus Therapeutics Inc.
Overview
Regulus Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Aiming to address unmet medical needs, the company specializes in novel therapies for diseases including fibrosis, metabolic diseases, and hepatitis C.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Regulus Therapeutics Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Amura Therapeutics Limited
United Kingdom
Akero Therapeutics, Inc.
United States
Celerion, Inc.
United States
Charles River Laboratories International, Inc.
United States
Esperion Therapeutics, Inc.
United States
FibroGen, Inc.
United States
Intercept Pharmaceuticals, Inc.
United States
Lassen Therapeutics, Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.